Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab

LC Cappelli, AK Gutierrez, AN Baer… - Annals of the …, 2017 - ard.bmj.com
Objectives Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated
protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have …

Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients

JJ Wisnieski, AN Baer, J Christensen, TR Cupps… - Medicine, 1995 - journals.lww.com
Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical... : Medicine
Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 …

Guillain‐Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy

ISJ Shin, AN Baer, HJ Kwon… - … : Official Journal of …, 2006 - Wiley Online Library
Objective Diverse neurologic syndromes have been described in association with tumor
necrosis factor α (TNFα) antagonist therapy for inflammatory arthritides and Crohn's disease. …

Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry

…, SC Shiboski, CH Shiboski, AN Baer… - Arthritis care & …, 2012 - Wiley Online Library
Objective To study the prevalence of extraglandular manifestations in primary Sjögren's
syndrome (SS) among participants enrolled in the Sjögren's International Collaborative Clinical …

Malignancy in myositis

ZA Zahr, AN Baer - Current rheumatology reports, 2011 - Springer
Dermatomyositis is associated with an underlying malignancy in about 24% of cases. This
association is also true for polymyositis but is less prominent. The malignancy is usually an …

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases

…, C Cheadle, AG Tzioufas, AN Baer… - Proceedings of the …, 2012 - National Acad Sciences
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …

Blunted erythropoietin response to anaemia in rheumatoid arthritis

AN Baer, EN Dessypris, E Goldwasser… - British journal of …, 1987 - Wiley Online Library
The relationship of serum immunoreactive erythropoietin to haemoglobin concentration was
defined for 54 patients with rheumatoid arthritis (RA) and 41 patients with anaemia of …

Molecular subsetting of interferon pathways in Sjögren's syndrome

JC Hall, AN Baer, AA Shah, LA Criswell… - Arthritis & …, 2015 - Wiley Online Library
Objective Sjögren's syndrome (SS) is an autoimmune disease that targets the salivary and
lacrimal glands. While all patients demonstrate inflammatory infiltration and abnormal …

Sicca syndrome associated with immune checkpoint inhibitor therapy

BM Warner, AN Baer, EJ Lipson, C Allen… - The …, 2019 - academic.oup.com
Background The objective of this study was to characterize the clinicopathologic features of
sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. Subjects, …

Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management

G Stojan, AN Baer - Expert review of clinical immunology, 2012 - Taylor & Francis
Systemic lupus erythematosus is a systemic autoimmune disease that primarily affects
women in their reproductive age years. Pregnancy in systemic lupus erythematosus now has …